In its latest report, Emkay Global Financial Services has maintained a ‘Reduce’ rating on Wipro Ltd., citing a soft Q4 performance and underwhelming guidance for Q1 FY26.
Sun Pharmaceutical Industries has received a favorable legal ruling in the United States that clears a key hurdle in launching Leqselvi, its much-anticipated treatment for alopecia areata.
Emkay Research has reaffirmed its BUY rating on Pricol, driven by its recent acquisition of the plastic injection molding business of Sundaram Auto Components (SAC).
Emkay Global Financial Services has initiated coverage on Anant Raj Limited (ARL) with a BUY recommendation, setting a target price of Rs 925, representing a 37% upside from its current price of Rs